{{Rsnum
|rsid=7757956
|Gene=ESR1
|Chromosome=6
|position=151996005
|Orientation=plus
|GMAF=0.1377
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=ESR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 6.2 | 23.4 | 70.3
| HCB | 0.0 | 6.7 | 93.3
| JPT | 2.3 | 18.2 | 79.5
| YRI | 11.1 | 39.7 | 49.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 6.7 | 93.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=ESTROGEN RECEPTOR 1; ESR1
|id=133430
|rsnum=7757956
}}

{{PMID Auto
|PMID=22011627
|Title=Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART.
}}
{{PMID Auto
|PMID=17105837
|Title=Estrogen receptor alpha regulates area-adjusted bone mineral content in late pubertal girls.
}}

{{PMID Auto
|PMID=17405848
|Title=Effect of an estrogen receptor-alpha intron 4 polymorphism on fat mass in 11-year-old children.
}}

{{PMID Auto
|PMID=18053221
|Title=Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
|OA=1
}}

{{PMID Auto
|PMID=19218192
|Title=Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
|OA=1
}}

{{PMID Auto
|PMID=22324545
|Title=Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy?
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}